Sort
30,917 grants matching “tumor microenvironment”
Understanding PPARgamma signaling in melanoma brain metastasis
$399,971Qing Chen · Wistar Institute · R01 · FY2022 · CA
Stroma-penetrating nanomedicine to improve treatment for pancreatic cancer
$399,970Katherine Marie Eichinger · Duo Oncology Inc · R41 · FY2024 · CA
Notch function in postnatal intestinal and mesenteric lymphatics
$399,961Carrie J. Shawber · Columbia University Health Sciences · R01 · FY2019 · DK
CD3 bispecific for the treatment of ROR2-positive NSCLC
$399,955Jean-Loup Romet-Lemonne · Traverse Biotech Ii Inc · R43 · FY2023 · CA
Project 3
$399,955Hideki Furuya · Methodist Hospital Research Institute · U54 · FY2025 · CA
Precision lung cancer therapy design through multiplexed adapter measurement
$399,937Aaron Samuel Meyer · University Of California Los Angeles · U01 · FY2019 · CA
Discovering Fusobacterium nucleatum's Impact on Breast Cancer Progression and Treatment with POx Micelle Technology
$399,829Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R21 · FY2025 · CA
New models for interrogating the impact of sex chromosomes and sex hormones on glioblastoma
$399,829Joseph Edward Ippolito · Washington University · R21 · FY2025 · CA
Human specific STING agonists for the treatment of cancer
$399,812Glen N Barber · Stinginn, Llc · R41 · FY2023 · CA
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
$399,806Yoon Yeo · Purdue University · R01 · FY2022 · CA
Transcriptional Regulation of Dormancy and Emergence in Breast Cancer
$399,784Partha Roy · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Informatics Tools To Analyze And Model Whole Slide Image Data At The Single Cell Level
$399,771Guanghua Xiao · Ut Southwestern Medical Center · U01 · FY2022 · CA
Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma
$399,752Deepak Saxena · Periomics Care, Llc · R41 · FY2020 · CA
Engineering a potent locally-acting interleukin 12-expressing synthetic self-replicating mRNA to augment responses to anti-PD-1 therapy in neoadjuvant triple negative breast cancer
$399,725Tasuku Kitada · Strand Therapeutics Inc · R43 · FY2021 · CA
Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles
$399,669Elizabeth E Sweeney · Immunoblue, Llc · R41 · FY2024 · CA
Simultaneous Targeting of Tumor and Stroma Cells to Enhance Solid Tumor CAR-T Cell Therapy
$399,658Nicole J. Shirkey-Son · Luminary Therapeutics, Inc. · R43 · FY2021 · CA
Phase II trial of ADXS11-001 vaccine for HPV-related oropharyngeal cancer
$399,622Andrew Sikora · Baylor College Of Medicine · R01 · FY2015 · FD
Development of Lasso Peptides as Potent Endothelin Receptor B Antagonists for Immuno-oncology
$399,609Mark J Burk · Lassogen, Inc. · R43 · FY2021 · CA
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$399,586Fatemeh Sadat Majedi · Symphony Biosciences, Inc. · R44 · FY2023 · CA
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
$399,582Raymond Nelson Dubois · Arizona State University-Tempe Campus · R01 · FY2015 · CA
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
$399,580Jacki Kornbluth · Vanquish Bio Llc · R41 · FY2022 · CA
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$399,571Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2023 · CA
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$399,569Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2022 · CA
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
$399,554K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2024 · CA
Abnormal Stem Cell Trafficking in IM
$399,509Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2011 · CA